Search results
Ondine Biomedical Inc. is a Canadian life sciences company that has become a global leader in photodisinfection-based therapies to prevent and treat a broad spectrum of infections, including those caused by drug-resistant pathogens.
About Ondine Biomedical Life sciences company headquartered in Vancouver, Canada. Leading the charge in breakthrough photodisinfection-based therapies to prevent and treat a broad spectrum of infections, including those.
Steriwave® Nasal Photodisinfection FOR HEALTHCARE Technology to reduce infections Steriwave® is a broad-spectrum antimicrobial providing targeted decolonization safely, effectively, quickly. Broad-spectrum: Kills all pathogens (bacterial, viral, fungal). Non-resistance forming.
Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing,...
Dec 13, 2023 · This cutting-edge technology replaces topical antibiotics for the prevention of healthcare-associated infections (HAIs) and kills all types of pathogens – bacteria, viruses and fungi – without...
Nov 16, 2023 · Ondine Biomedical Inc. is a Canadian life science company pioneering the field of photodisinfection therapies. Ondine has a pipeline of investigational products, based on its...
Sep 6, 2022 · Ondine has developed a patented, photodisinfection technology platform used in treatment and prevention therapies for a broad-spectrum of pathogens – including multidrug-resistant strains....
Nov 13, 2023 · Ondine’s nasal photodisinfection technology, which has been significantly reducing hospital acquired infections, uses a combination of a photosensitive agent and red laser light to...
Mar 3, 2023 · Ondine Biomedical Inc. is a Canadian company innovating in the field of photodisinfection therapies. Ondine has a pipeline of investigational products, based on its proprietary...
Aug 8, 2022 · VANCOUVER, BC, Aug. 8, 2022 /PRNewswire/ -- Ondine Biomedical Inc. (LON: OBI), has recruited the final patient to its nasal photodisinfection exploratory Phase 2 trial. The trial is evaluating...
